August 22, 2013 — The American Society of Nuclear Cardiology (ASNC) has recently released an online education program for physicians and technologists involved in the practice of nuclear cardiology. This program offers continuing education credits and provides valuable quality control procedures and radiation safety information.

“Patient-Centered Imaging: Strategies for Reducing Radiation Dose Levels in Nuclear Cardiology Studies” is an interactive case-based online CME/CE activity designed to increase learners’ competence on the appropriateness of cardiac imaging testing and the rationale for reducing exposure to ionizing radiation in adults who are at risk for coronary artery disease. The activity is a valuable guide for healthcare professionals, including hospital practice administrators, who are involved in the field of nuclear cardiology.

The objectives of the program are for participants, upon completion of this online educational activity, to be able to:

  • Demonstrate the importance of using appropriate use criteria to select the nuclear imaging tests and radiopharmaceuticals that will result in the lowest possible dose of radiation;
  • Review factors that influence use of radiation exposure (age, medical condition, etc.); and
  • Demonstrate techniques, technologies, software applications and acquisition parameters that will reduce radiation exposure.


The program faculty includes ASNC’s current president, James A. Arrighi, M.D., FASNC (Rhode Island Hospital/Alpert Medical School of Brown University), and vice president, Brian G. Abbott, M.D., FASNC (Rhode Island Cardiology Center/Alpert Medical School of Brown University). Additional faculty includes Gordon DePuey, M.D., FASNC; April Mann, CNMT, RT(N), NCT, FASNC; Leslee J. Shaw, Ph.D., FASNC; Kim A. Williams, Sr., M.D., FASNC; and Jack A. Ziffer, M.D., Ph.D., FASNC.

For more information: http://www.asnc.org/content_15364.cfm


Related Content

News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 14, 2024 — PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of ...

Time February 14, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | PET Imaging

February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before ...

Time February 09, 2024
arrow
News | SNMMI

February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...

Time February 06, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
Subscribe Now